Nuacht

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best Russell 2000 stocks to buy now. On August 18, Truist Securities ...
Zacks Investment Research on MSN19 uair an chloig

Hims & Hers Fuels Growth via Market Expansion and New Care Verticals

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is building its market opportunity around ...
StockStory.org on MSN12 uair an chloig

Why Hims & Hers Health (HIMS) Stock Is Falling Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.4% in the afternoon session after investors took some ...
Meta (META) stock is dipping on reports that the company is restructuring its artificial intelligence (AI) unit for the ...
The telehealth-consultation platform posted an increase in profit and revenue for the second quarter on growth in subscribers using personalized treatment plans.
Hims & Hers previously has announced partnerships with some health systems, including Privia, ChristianaCare, and even one with another healthcare disruptor, primary care upstart Carbon Health.
Hims & Hers Health, a telehealth platform that sells knockoffs of popular weight loss drugs, sank in after-hours trading ...
Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...
What To Know: Under the agreement, all strengths of the medications will now be available to eligible self-paying patients at $499 per month through GoodRx's platform.
SHOPPING: Enter Hers , the company offering a streamlined and more accessible option - without insurance, appointments, and ...
Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...
Shares of Hims & Hers Inc. fell after hours on Monday after the wellness and telehealth platform’s third-quarter forecast ...